Artwork

Inhoud geleverd door Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Ep71: Learning from AI: Lessons for Digital Therapeutic Pioneers

34:47
 
Delen
 

Manage episode 372830575 series 2857558
Inhoud geleverd door Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 afleveringen

Artwork
iconDelen
 
Manage episode 372830575 series 2857558
Inhoud geleverd door Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal government as the associate director of FDA’s Oncology Center of Excellence and the founding executive director of FDA INFORMED, a data science and technology incubator he established under special authorities from the US department of health and human services.

Topics include:

  • How are Braven Partners incubating and supporting minimally viable ecosystems of companies that can make a difference?
  • What are the goals of the Alliance for Artificial Intelligence in Healthcare?
  • How can digital therapeutics developers ensure effective reimbursement for their products in the healthcare industry?
  • How is the ethos of AI in healthcare speaking to a culture that is focused on safety without compromising innovation?
  • How do we demystify new tools and technologies such as AI?
  • How does the FDA think about regulating AI?
  • What can digital therapeutic manufacturers companies, entrepreneurs and trailblazers learn from the Alliance for Artificial Intelligence in Healthcare (AAIH)?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

103 afleveringen

Tous les épisodes

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding